Literature DB >> 28343775

Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake.

Anu Jain1, A J van Hoek2, Delia Boccia3, Sara L Thomas4.   

Abstract

INTRODUCTION: Vaccination is a key intervention to reduce infectious disease mortality and morbidity amongst older individuals. Identifying social factors for vaccine uptake enables targeted interventions to reduce health inequalities.
OBJECTIVE: To systematically appraise and quantify social factors associated with vaccine uptake amongst individuals aged ≥60years from Europe.
METHODS: We searched Medline and Embase from inception to 24/02/2016. The association of vaccine uptake was examined for social factors relevant at an individual level, to provide insight into individuals' environment and enable development of targeted interventions by healthcare providers to deliver equitable healthcare. Factors included: living alone, marital status, education, income, vaccination costs, area-level deprivation, social class, urban versus rural residence, immigration status and religion. Between-study heterogeneity for each factor was identified using I2-statistics and Q-statistics, and investigated by stratification and meta-regression analysis. Meta-analysis was conducted, when appropriate, using fixed- or random-effects models.
RESULTS: From 11,754 titles, 35 eligible studies were identified (uptake of: seasonal influenza vaccine (SIV) only (n=27) or including pneumococcal vaccine (PV) (n=5); herpes zoster vaccine (n=1); pandemic influenza vaccine (n=1); PV only (n=1)). Higher SIV uptake was reported for individuals not living alone (summary odds ratios (OR)=1.39 (95% confidence interval (CI): 1.16-1.68). Lower SIV uptake was observed in immigrants and in more deprived areas: summary OR=0.57 (95%CI: 0.47-0.68) and risk ratio=0.93 (95%CI: 0.92-0.94) respectively. Higher SIV uptake was associated with higher income (OR=1.26 (95%CI: 1.08-1.47)) and higher education (OR=1.05 (95%CI: 1-1.11)) in adequately adjusted studies. Between-study heterogeneity did not appear to result from variation in categorisation of social factors, but for education was partly explained by varying vaccination costs (meta-regression analysis p=<0.0001); individuals with higher education had higher vaccine uptake in countries without free vaccination.
CONCLUSIONS: Quantification of associations between social factors and lower vaccine uptake, and notably living alone (an overlooked factor in vaccination programmes), should enable health professionals target specific social groups to tackle vaccine-related inequalities.
Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Inequalities; Living alone; Meta-analysis; Older; Social determinants; Vaccine uptake

Mesh:

Substances:

Year:  2017        PMID: 28343775     DOI: 10.1016/j.vaccine.2017.03.013

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Facilitators and barriers to completing recommended doses of pneumococcal vaccination among community-living individuals aged ≥65 years in Hong Kong - a population-based study.

Authors:  Zixin Wang; Yuan Fang; Margaret Ip; Mason Lau; Joseph T F Lau
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

2.  Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies.

Authors:  Xinhui Wu; Haixia Yang; Sixian He; Ting Xia; Diang Chen; Yexin Zhou; Jin Liu; MengSi Liu; Zhen Sun
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

3.  Barriers to COVID-19 vaccination among older adults in Mexico City.

Authors:  Pablo Gaitán-Rossi; Miranda Mendez-Rosenzweig; Erika García-Alberto; Mireya Vilar-Compte
Journal:  Int J Equity Health       Date:  2022-06-19

4.  The role of social determinants in timely herpes zoster vaccination among older American adults.

Authors:  Sohul Shuvo; Tracy Hagemann; Kenneth Hohmeier; Chi-Yang Chiu; Sujith Ramachandran; Justin Gatwood
Journal:  Hum Vaccin Immunother       Date:  2021-01-30       Impact factor: 3.452

Review 5.  Adult preventive vaccines with other synergistic lifestyle options: is it time to add these ancillary benefits to the overall AS management checklist?

Authors:  Mark A Moyad
Journal:  World J Urol       Date:  2021-05-07       Impact factor: 4.226

6.  Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ≥65 Years - United States, December 14, 2020-April 10, 2021.

Authors:  Ari Whiteman; Alice Wang; Kelly McCain; Betsy Gunnels; Robin Toblin; James Tseryuan Lee; Carolyn Bridges; Laura Reynolds; Bhavini Patel Murthy; Judy Qualters; James A Singleton; Kimberley Fox; Shannon Stokley; LaTreace Harris; Lynn Gibbs-Scharf; Neetu Abad; Kathryn A Brookmeyer; Susan Farrall; Cassandra Pingali; Anita Patel; Ruth Link-Gelles; Sharoda Dasgupta; Radhika Gharpure; Matthew D Ritchey; Kamil E Barbour
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-05-14       Impact factor: 17.586

7.  Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis.

Authors:  Claire Glenton; Benedicte Carlsen; Simon Lewin; Manuela Dominique Wennekes; Brita Askeland Winje; Renske Eilers
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20

8.  Behavioral determinants for vaccine acceptability among rurally located college students.

Authors:  Rebecca K Britt; Andrew M Englebert
Journal:  Health Psychol Behav Med       Date:  2018-09-06

9.  COVID-19 Vaccination Intentions: The Theory of Planned Behavior, Optimistic Bias, and Anticipated Regret.

Authors:  Katharina Wolff
Journal:  Front Psychol       Date:  2021-06-16

10.  Identifying social factors amongst older individuals in linked electronic health records: An assessment in a population based study.

Authors:  Anu Jain; Albert J van Hoek; Jemma L Walker; Rohini Mathur; Liam Smeeth; Sara L Thomas
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.